SCHEMBL9508214

SCHEMBL9508214

COc1ccc2nc(Nc3ccccc3C)nc(N(C)c3ccccc3)c2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9776711 0.99 CSF1R (0.57)
SCHEMBL9511897 0.89
Hydrochloric Acid SCHEMBL9776710 0.87 EGFR (0.63)
Hydrochloric Acid SCHEMBL9776743 0.86 EGFR (0.56)
SCHEMBL9508870 0.84
SCHEMBL9776705 0.83 NPC1 (0.59)
Bromide SCHEMBL9508831 0.83
Hydrochloric Acid SCHEMBL9776836 0.82 NPC1 (0.61)
Hydrochloric Acid SCHEMBL9776921 0.82 NPC1 (0.61)
SCHEMBL9508208 0.81 SLC2A1 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0404322-B1 QUINAZOLINE DERIVATIVES SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1993-09-22 EP disclosed
US-5064833-A Substituted quinazoline derivatives for use in gastrointestinal diseases SMITHKLINE BEECHAM INTERCREDIT B.V. (GB) 1991-11-12 US disclosed
EP-0404322-A1 Quinazoline derivatives SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1990-12-27 EP disclosed